IRIS
MAFFEZZINI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.523
AS - Asia 584
NA - Nord America 259
SA - Sud America 47
AF - Africa 14
Totale 7.427
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.427
SG - Singapore 320
US - Stati Uniti d'America 242
CN - Cina 129
VN - Vietnam 70
FR - Francia 54
BR - Brasile 25
HK - Hong Kong 19
DE - Germania 15
MX - Messico 11
AR - Argentina 10
JP - Giappone 10
GB - Regno Unito 7
ID - Indonesia 7
IQ - Iraq 6
CO - Colombia 5
IN - India 5
NL - Olanda 5
BD - Bangladesh 4
CA - Canada 4
CH - Svizzera 3
IE - Irlanda 3
KZ - Kazakistan 3
RU - Federazione Russa 3
VE - Venezuela 3
EC - Ecuador 2
MY - Malesia 2
NA - Namibia 2
SA - Arabia Saudita 2
SE - Svezia 2
ZA - Sudafrica 2
AO - Angola 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
MR - Mauritania 1
NP - Nepal 1
PL - Polonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 7.427
Salva come PNG Salva come JPEG
Città #
Genova 3.863
Genoa 1.340
Rapallo 729
Vado Ligure 435
Singapore 163
San Jose 126
Lauterbourg 52
Bordighera 50
Ashburn 45
Ho Chi Minh City 24
Hong Kong 17
Santa Clara 16
New York 15
Frankfurt am Main 12
Hanoi 11
Beijing 10
Mexico City 8
Tokyo 8
Amsterdam 5
Biên Hòa 4
Haiphong 4
São Paulo 4
Denver 3
Dublin 3
Hải Dương 3
Brasília 2
Bắc Ninh 2
Caracas 2
Guayaquil 2
Gurugram 2
Lausanne 2
London 2
Nuremberg 2
Orem 2
Posadas 2
Riyadh 2
Semarang 2
Shanghai 2
Stockholm 2
Windhoek 2
Abidjan 1
Al Diwaniyah 1
Al Hillah 1
Almaty 1
Astana 1
Atlanta 1
Baghdad 1
Baku 1
Baltimore 1
Bandung 1
Barranquilla 1
Beit Jann 1
Benito Juarez 1
Boardman 1
Bogotá 1
Bourges 1
Bristol 1
Buenos Aires 1
Buffalo 1
Bình Dương 1
Bình Phước 1
Campo Grande 1
Cardiff 1
Caserta 1
Chaguanas 1
Chandigarh 1
Chennai 1
Chicago 1
Chilecito 1
Chimbas 1
Chongqing 1
City of London 1
Ciudad del Libertador General San Martín 1
Colina 1
Compton 1
Craiova 1
Custódia 1
Da Nang 1
Dakar 1
Dallas 1
Dhaka 1
Djelfa 1
Doha 1
Formosa 1
Forquilhinha 1
Giza 1
Goderich 1
Guanambi 1
Ha Long 1
Houston 1
Itaquaquecetuba 1
Jordan 1
Jupiter 1
Karbala 1
Kosiv 1
Kuala Lumpur 1
Leipzig 1
Livramento de Nossa Senhora 1
Longueuil 1
Los Angeles 1
Totale 7.040
Salva come PNG Salva come JPEG
Nome #
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry. 178
Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle invasive bladder cancer. 171
Bladder cell culture on small intestinal submucosa as bioscaffold: Experimental study on engineered urothelial grafts 170
Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study. 165
Large bladder diverticula: a comparison between laparoscopic excision and endoscopic fulguration 164
Developing a five-step training model for transperineal prostate biopsies in a naïve residents’ group: a prospective observational randomised study of two different techniques 162
A Multimodal Perioperative Plan for Radical Cystectomy and Urinary Intestinal Diversion: Effects, Limits and Complications of Early Artificial Nutrition 161
Pre-operative assessment of cancer in the elderly (PACE): A comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery 158
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 157
Evaluation of complications and results in a contemporary series of 300 consecutive radical retropubic prostatectomies with the anatomic approach at a single institution 153
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help - A SIOG surgical task force prospective study. 153
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation 151
Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease 150
A prognostic model including pre- and postsurgical variables to enhance risk stratification of primary mediastinal nonseminomatous germ cell tumors: the 27-year experience of a referral center. 148
A Simple Mathematical Approach to Calculate Blood Loss in Radical Prostatectomy 147
Estimates of prostate cancer burden in Italy. 146
Incidence and survival of rare urogenital cancers in Europe. 145
Age Is Predictive of Immediate Postoperative Urinary Continence after Radical Retropubic Prostatectomy 144
"What if…": decisional regret in patients who discontinued active surveillance 142
Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center. 139
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer. 137
Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus 137
Multimodal Perioperative Plan for Radical Cystectomy and Intestinal Urinary Diversion. I. Effect on Recovery of Intestinal Function and Occurrence of Complications 133
Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch 132
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma. 131
Postchemotherapy lymphadenectomy in patients with metastatic urothelial carcinoma: long-term efficacy and implications for trial design 129
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder 126
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy. 126
Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer 126
The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis. 125
Active surveillance in young patients with prostate cancer: the unanswered question 125
For wider acceptance of radical cystectomy and extended pelvic lymphadenectomy 119
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. 118
Feeding Hungry Patients, Even Those Well Nourished 117
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. 116
Editorial comment on: long-term rates of undetectable psa with initial observation and delayed salvage radiotherapy after radical prostatectomy 116
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome. 113
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation. 111
Short-Schedule Intravesical Gemcitabine with Ablative Intent in Recurrent Ta–T1, G1–G2, Low- or Intermediate-Risk, Transitional Cell Carcinoma of the Bladder 108
Systemic Absorption and Pharmacokinetics of Single-dose Intravesical Gemcitabine After Transurethral Resection of the Bladder in Non-muscle-invasive Bladder Cancer 108
Osteopontin plasma levels does not detect prostate cancer in patientsreferred for diagnostic biopsy 107
Re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-Day Mortality after Nephrectomy: Clinical Implications for Informed Consent. Eur Urol 2009;56:998-1005 107
TC Incidence Increasing: Spread the Word 105
Re: Trends in hospital volume and operative mortality for high-risk surgery 105
Focal therapy in urology: kidney cancer 104
Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression. 103
Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature. 102
Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer 100
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial. 98
Paraganglioma of the prostate in a young adult 98
High-Risk Prostate Cancer is Worth Further Risk Stratification 97
Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies 97
The magnitude of the problem and the burden of physicians and patient decisions 96
Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderly. 96
Systemic Absorption and Pharmacokinetics of Single-Dose, Post-TURB (Trans-Urethral Resection of Bladder), Intravesical Gemcitabine, in Non-Muscle Invasive Bladder Cancer. 95
Bladder Cancer 89
Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability. 85
Urinary Diversion and Morbidity After Radical Cystectomy for Bladder Cancer 73
Prognostic Significance of Fluorescent In Situ Hybridisation in the Follow-up of Non-muscle-invasive Bladder Cancer 69
The survival of patients with bone metastases from renal cell carcinoma 62
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading. 47
Totale 7.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.663
article - articoli 24.322
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 341
Totale 49.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021136 0 0 0 0 0 0 0 0 0 71 30 35
2021/2022818 30 83 67 71 23 78 50 162 65 64 41 84
2022/2023856 74 47 3 96 102 146 0 99 142 3 138 6
2023/2024323 22 42 6 39 16 52 14 51 15 11 24 31
2024/2025990 5 84 23 58 150 143 64 152 49 61 110 91
2025/20261.395 170 14 109 106 268 197 278 62 83 108 0 0
Totale 7.492